This webinar will provide an introduction to two recently published Research Opportunity Announcements (ROAs) for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT): OTA-24-013(pdf, 311 KB) NeuroNEXT Clinical Trials Stage 1 Preliminary Application; and OTA-24-014(pdf, 836 KB), NeuroNEXT Clinical Trials Stage 2 Protocol Application. NeuroNEXT provides robust, standardized, and accessible infrastructure, designed to facilitate the development and conduct of Phase 2 clinical trials or biomarker studies focused on neurological diseases in pediatric and adult populations. The webinar will provide information on NeuroNEXT's new two-stage application and review process and offer a forum for potential applicants to ask questions.
An official website of the United States government
Official websites use .gov
A
.gov
website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock
(
)
or
https://
means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.